XML 39 R77.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity And Benefit Plans (Schedule Of Stock Option And Stock Appreciation Rights Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Jan. 01, 2011
Jan. 02, 2010
Jan. 03, 2009
Stockholders' Equity And Benefit Plans [Abstract]        
Outstanding, Shares 1,220 1,400 2,811 2,858
Outstanding, Weighted-Average Exercise Price $ 41.20 $ 25.55 $ 21.21 $ 21.09
Outstanding, Weighted-Average Remaining Contractual Term (Years) 5.8 5.8 5.3 5.7
Outstanding, Aggregate Intrinsic Value $ 49,125 $ 62,889 $ 35,217 $ 5,862
Granted, Shares 303 325 317  
Granted, Weighted-Average Exercise Price $ 87.73 $ 38.37 $ 13.65  
Exercised, Weighted-Average Exercise Price $ 23.95 $ 19.98 $ 12.03  
Exercised, Aggregate Intrinsic Value 33,267 47,073 4,935  
Forfeited or expired, Shares (22) (240) (49)  
Exercised, Shares (461) (1,496) 315  
Forfeited or expired, Weighted-Average Exercise Price $ 47.44 $ 26.82 $ 24.13  
Exercisable at December 31, 2011 496      
Exercisable at December 31, 2011, Weighted-Average Exercise Price $ 30.95      
Exercisable at December 31, 2011, Weighted-Average Remaining Contractual Term (Years) 3.9      
Exercisable at December 31, 2011, Aggregate Intrinsic Value 25,346      
Nonvested at December 31, 2011, 2011, Shares 724      
Nonvested at December 31, 2011, Weighted-Average Exercise Price $ 48.21      
Nonvested at December 31, 2011, Weighted-Average Remaining Contractual Term (Years) 7.2      
Nonvested at December 31, 2011, Aggregate Intrinsic Value 23,779      
Expected to vest, Shares 671      
Expected to vest, Weighted-Average Exercise Price $ 48.21      
Expected to vest, Weighted-Average Remaining Contractual Term (Years) 7.2      
Expected to vest, Aggregate Intrinsic Value $ 22,091